Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

Office and ambulatory BP improved, with minimal side effects, although some say edema needs to be watched carefully.

“Only portable power banks with serial numbers 000G21, 000H21, 000I21 and 000L21 are included in this recall,” the CPSC says.

Equity Insider News Commentary ? The oncology sector's pivot toward platform-based precision therapies has signaled smart money abandoning single-asset risk for companies engineering multiple drugs ...

Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...

We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Samantha Schoech Samantha ...

After back-to-back games last month in which AJ Dybantsa shot below 38% from the field, the five-star freshman has mostly been cooking. In BYU's past five contests, all of them wins, Dybantsa is ...

Sacituzumab govitecan showed lower rates of dose reductions and treatment discontinuations due to adverse effects compared to chemotherapy in TNBC patients. Common adverse effects, such as diarrhea ...

The annual meeting of the American Society of Hematology was held from Dec. 6 to 9 in Orlando, Florida, and attracted ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...